Latest Organ failure Stories
BOSTON, May 17, 2013 /PRNewswire/ -- TechAtlas Group has announced the release of the latest update for their competitive landscape map for the Chronic Kidney Disease (CKD) market. This particular landscape highlights over 90 international companies with drugs and devices currently on the market and in development addressing CKD and its sequelae. (Logo: http://photos.prnewswire.com/prnh/20130517/NE16011LOGO ) Topics include: hypertension - renal denervation diabetic nephropathy...
-Analysis of Recurrent Heart Failure Hospitalizations in Presence of Informative Censoring - Application of Joint Frailty Model- SAN DIEGO, May 8, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases, announced today that it will present analysis methods for the MYDICAR development program at an upcoming Conference. The conference "Statisticians in the Pharmaceutical...
Keryx to Host Investor Conference Call on Wednesday, May 8, 2013 at 8:30am EDT NEW YORK, May 7, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease (the "Company"), today announced its results for the first quarter ended March 31, 2013. At March 31, 2013, the Company had cash and cash equivalents...
SAN DIEGO, May 7, 2013 /PRNewswire/ -- Celladon Corporation, a biopharmaceutical company focused on the discovery and development of innovative treatments for cardiovascular diseases announced today it had been selected as a finalist for Red Herring's Top 100 North America award, a prestigious list honoring the year's most promising private technology ventures from the North American business region. Red Herring has been selecting the most exciting and promising start-ups and...
Cinacalcet, a drug commonly given to patients with end stage kidney disease to help keep phosphorus and parathyroid blood levels within a target range and has few patient level clinical benefits and several adverse effects, suggesting that it should no longer be routinely prescribed, according to a study by international researchers published in this week's PLOS Medicine. These findings are important as cinacalcet has become the largest single drug cost for patients on dialysis in the US,...
Novel treatment has potential in multiple cardiovascular diseases Up to 10 per cent of patients with high blood pressure are resistant to treatment, which puts them at increased risk of cardiovascular events, including heart attacks. Clinical trials show that catheter-based renal denervation reduces blood pressure in patients who do not respond to conventional drug therapy. Use of the technique is increasing in Europe and worldwide and several national societies have published guidance...
April Flowers for redOrbit.com - Your Universe Online The American Heart Association (AHA) issued a statement this week that predicts the number of people with heart failure could rise 46 percent – from 5 million in 2012 to 8 million in 2030 – and that the direct and indirect costs to treat heart failure could more than double -- from $31 billion in 2012 to $70 billion in 2030. This means every US taxpayer could be paying $244 a year to care for heart failure patients by 2030. The...
The American Kidney Fund (AKF) announced Jonathan Rivera Gómez from Mayaguez, Puerto Rico as the young artist who won the organization’s Calendar Kids art contest for pediatric kidney patients. Rockville, MD (PRWEB) April 22, 2013 The American Kidney Fund (AKF) announced Jonathan Rivera Gómez from Mayaguez, Puerto Rico as the young artist who won the organization’s Calendar Kids art contest for pediatric kidney patients. More than 6,700 people nationwide cast online votes to...
Eco-friendly Kidney Cars Program Saves Lives NEW YORK, April 22, 2013 /PRNewswire-USNewswire/ -- The old car sitting in your driveway can breathe new life into the environment, your pocketbook and those suffering from kidney disease. This Earth Day, donate the car to Kidney Cars and become eligible for a tax deduction while helping the National Kidney Foundation get more mileage out of its education and prevention programs. (Photo:...
Lower extremity physical performance tests may help identify patients at risk Highlights: -In patients with chronic kidney disease, measures of lower extremity performance were at least 30% lower than predicted, but handgrip strength was relatively preserved. -Each 0.1-meter per second slower walking speed was linked with a 26% higher risk for death over an average three-year follow-up period. -Adding gait speed tests to laboratory tests of kidney function significantly improved the...
